MS Relapse Rate Not Increased After Fertility Treatments
THURSDAY, March 16, 2023 (HealthDay News) — For women with multiple sclerosis (MS), there is no increased relapse rate after fertility treatment (FT), according to a study published online March 15 in Neurology, Neuroimmunology & Neuroinflammation.Ed…
Learn MoreJust 2 Kids Worldwide Are Known to Have This Rare Genetic Disease. Their Parents United for a Cure
THURSDAY, March 16, 2023 (HealthDay News) — When Yoni Silverman, now 13, was a toddler, his parents fretted as he missed milestone after milestone. The New York City couple took their son to a host of specialists, searching for answers about why he w…
Learn MoreFertility Treatments Pose No Danger to People With MS
THURSDAY, March 16, 2023 (HealthDay News) — Women with multiple sclerosis who want to undergo fertility treatment can do so without worry, according to a new study. Participants who had MS were no more likely to have a flare-up of the disease after r…
Learn MoreLa FDA aprueba un nuevo aerosol nasal para las migrañas
LUNES, 13 de marzo de 2023 (HealthDay News) — Las personas que sufren migrañas pronto contarán con una nueva opción de tratamiento que funciona con una mayor rapidez, y que quizá sea más segura para las personas en riesgo de ataque cardiaco y acciden…
Learn MoreFDA Approves First Treatment for Rett Syndrome
TUESDAY, March 14, 2023 (HealthDay News) – The U.S. Food and Drug Administration has approved Daybue (trofinetide) for the treatment of Rett syndrome in adult and pediatric patients aged 2 years and older.Approval was based on results from the phase 3…
Learn MoreNew Nasal Spray for Migraines Approved by FDA
MONDAY, March 13, 2023 (HealthDay News) — The U.S. Food and Drug Administration has approved Pfizer’s zavegepant (Zavzpret), a calcitonin gene-related peptide receptor antagonist nasal spray meant to treat severe headache pain, the company announced …
Learn MoreNew Nasal Spray for Migraines Approved by FDA
MONDAY, March 13, 2023 (HealthDay News) – Migraine sufferers will soon have a new treatment option that works more quickly and may be safer for people at risk of heart attack or stroke. The U.S. Food and Drug Administration has approved Pfizer Inc.’s …
Learn MoreCBD Oil Won’t Ease Pain After Kidney Stone Treatment
MONDAY, March 13, 2023 (HealthDay News) — An approved CBD oil product will, apparently, not be the solution for patients trying to reduce pain after kidney stone treatment, a randomized clinical trial suggests.”Urologists and patients alike are inter…
Learn MoreHydrochlorothiazide Does Not Affect Recurrence of Kidney Stones
FRIDAY, March 10, 2023 (HealthDay News) — Hydrochlorothiazide does not reduce the risk for recurrence among patients with recurrent kidney stones, according to a study published in the March 2 issue of the New England Journal of Medicine.Nasser A. Dh…
Learn MoreUn gen que protegió a algunos de la peste negra podría ayudar, y hacer daño, a las personas hoy en día
MIÉRCOLES, 8 de marzo de 2023 (HealthDay News) — Algunas personas podrían portar un gen que ayuda a protegerlos de enfermedades respiratorias como la COVID-19, y que ayudó a sus ancestros a luchar contra la peste.Pero se cobra un precio.Esta misma va…
Learn More